Association of arterial stiffness and electrocardiography-determined left ventricular hypertrophy with left

Po-Chao Hsu1, Wei-Chung Tsai, Tsung-Hsien Lin

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Plos One
|November 13, 2012
PubMed

Insights

Higher arterial stiffness, measured by brachial-ankle pulse wave velocity (baPWV), and electrocardiography-determined left ventricular hypertrophy (LVH) are independently linked to left ventricular diastolic dysfunction (LVDD). These factors help identify individuals at high risk for LVDD.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Increased arterial stiffness is linked to left ventricular diastolic dysfunction (LVDD).
  • Left ventricular hypertrophy (LVH) influences left ventricular (LV) performance and is correlated with LVDD.
  • The interplay between arterial stiffness, LVH, and LVDD requires further investigation.

Purpose of the Study:

  • To compare LV diastolic function in patients stratified by brachial-ankle pulse wave velocity (baPWV) and electrocardiography (ECG)-determined LVH.
  • To determine if elevated baPWV and ECG-determined LVH are independent predictors of LVDD.

Main Methods:

  • A cross-sectional study of 270 patients categorized into four groups based on median baPWV and presence/absence of ECG-determined LVH.
  • baPWV measured using an ABI-form device; LVH defined by Sokolow-Lyon criterion.
  • LVDD defined by impaired relaxation, pseudonormal, or restrictive mitral inflow patterns.

Main Results:

  • Early diastolic mitral velocity (Ea) decreased progressively across the four groups.
  • The group with high baPWV and LVH exhibited the highest prevalence of LVDD.
  • Both baPWV and ECG-determined LVH were independent predictors of reduced Ea and increased LVDD risk.

Conclusions:

  • Patients with higher baPWV and ECG-determined LVH have poorer LV diastolic function and higher LVDD prevalence.
  • baPWV and ECG-determined LVH are independently associated with Ea and LVDD.
  • Assessing arterial stiffness (baPWV) and LVH (ECG) can identify individuals at high risk for LVDD.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...